Truist Financial Lowers Humana (NYSE:HUM) Price Target to $285.00

Humana (NYSE:HUM) had its target price decreased by equities researchers at Truist Financial from $300.00 to $285.00 in a report issued on Monday,Benzinga reports. The firm currently has a “hold” rating on the insurance provider’s stock. Truist Financial’s target price suggests a potential upside of 17.34% from the company’s current price.

HUM has been the subject of a number of other research reports. Bank of America increased their price target on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Evercore ISI assumed coverage on shares of Humana in a research report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective for the company. Guggenheim restated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Barclays lowered their target price on Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a report on Friday, October 3rd. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $298.39.

Humana Price Performance

Shares of NYSE:HUM traded down $9.16 during mid-day trading on Monday, reaching $242.89. The stock had a trading volume of 562,150 shares, compared to its average volume of 1,762,685. The business’s 50 day moving average price is $278.04 and its 200 day moving average price is $258.86. Humana has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a market cap of $29.21 billion, a P/E ratio of 18.64, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.16 EPS. Research analysts expect that Humana will post 16.47 EPS for the current fiscal year.

Institutional Investors Weigh In On Humana

A number of institutional investors and hedge funds have recently modified their holdings of HUM. Cary Street Partners Investment Advisory LLC raised its position in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares during the last quarter. Elevation Point Wealth Partners LLC purchased a new position in shares of Humana during the second quarter worth $32,000. Mather Group LLC. purchased a new position in shares of Humana during the third quarter worth $34,000. Zions Bancorporation National Association UT acquired a new stake in Humana during the 1st quarter worth about $37,000. Finally, AlphaCore Capital LLC acquired a new stake in Humana during the 2nd quarter worth about $39,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.